Smac peptidomimetics useful as IAP inhibitors

Details for Australian Patent Application No. 2007281230 (hide)

Owner Novartis AG

Inventors Lei, Huangshu; Charest, Mark G.; Chen, Zhuoliang; He, Feng; Zawel, Leigh; Dai, Miao; Sharma, Sushil Kumar; Chen, Christine Hiu-Tung; Pham, Ly Luu; Straub, Christopher Sean; Wang, Run-Ming David; Yang, Fan

Agent Davies Collison Cave

Pub. Number AU-B-2007281230

PCT Pub. Number WO2008/016893

Priority 60/835,000 02.08.06 US

Filing date 31 July 2007

Wipo publication date 7 February 2008

Acceptance publication date 8 September 2011

International Classifications

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4439 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

12 February 2009 PCT application entered the National Phase

  PCT publication WO2008/016893 Priority application(s): WO2008/016893

8 September 2011 Application Accepted

  Published as AU-B-2007281230

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007281234-Kit and methods of treatment of an intervertebral disc

2007281229-Multiple rod system with elastic rodcontaining means